Target stock's growth faces risks from Amazon and margin pressures. Learn if TGT is a value trap before you invest.

Target Corporation’s net debt/EBITDA at 1.8x signals solid credit quality despite earnings and revenue declines. Heavy CAPEX on Ulta partnership and store renovations failed to drive sustainable sales ...

In the rapidly evolving landscape of modern biotechnology, the precision of molecular tools determines the speed of medical breakthroughs. As a Global Leading Biotinylated Peptide Synthesis specialist ...

For years, beauty brands focused on millennials, then pivoted hard toward Gen Z. Now, attention is shifting again. Gen Alpha, ...

Novartis is taking another shot at alpha-synuclein as a target for treating Parkinson’s disease via a $200 million upfront licensing deal with Arrowhead Pharmaceuticals. The Swiss pharma plans to use ...

A section of the document, titled “2026 Budget and Strategies at Improving IGR,” points to an aggressive revenue drive coming at a time when Nigerians are grappling with severe economic pressure, ...